description: Tumor was obtained from a 50 year-old African American male who was diagnosed with Intrahepatic cholangiocarcinoma. A metastatic lymph node from the porta hepatis was resected, from which the cell line was derived. A patient-derived xenograft (PDX) was generated by injecting minced tumor into the flank of NSG mice. The PDX was monitored for growth, passaged as a second generation to additional mice, and ultimately used to establish a 2-D patient derived cell line (PDC), PDC-DUC18828.
attributes.tag: isolate
attributes.value: Tissue sample
attributes.tag: age
attributes.value: 50 years
attributes.tag: biomaterial_provider
attributes.value: Michael E. Lidsky, Dept of Surgery, Box 3966, Durham, NC 27710
attributes.tag: sex
attributes.value: male
attributes.tag: tissue
attributes.value: Intrahepatic cholangiocarcinoma isolated from the porta hepatis lymph node
attributes.tag: cell_line
attributes.value: DUC18828
attributes.tag: cell_type
attributes.value: Intrahepatic cholangiocarcinoma cell
attributes.tag: dev_stage
attributes.value: Adult
attributes.tag: disease
attributes.value: DOID:4928, intrahepatic cholangiocarcinoma
attributes.tag: disease_stage
attributes.value: metastatic
attributes.tag: ethnicity
attributes.value: African-american
attributes.tag: phenotype
attributes.value: malignant cell
attributes.tag: sample_type
attributes.value: cell culture
attributes.tag: BioSampleModel
attributes.value: Human